SCHEMBL392083

SCHEMBL392083

NC1CC(N)C(N)CC1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GABRR1 P24046 1/20 0.35
MAOA P21397 7/20 0.32
MAOB P27338 7/20 0.32
KDM1A O60341 5/20 0.32
CYP2C19 P33261 4/20 0.30
FUCA1 P04066 3/20 0.30
CYP2B6 P20813 3/20 0.30
SLC6A12 P48065 2/20 0.30
SLC6A11 P48066 2/20 0.30
SLC6A13 Q9NSD5 2/20 0.30
CYP1A2 P05177 2/20 0.30
CYP2D6 P10635 2/20 0.30
CYP2C9 P11712 2/20 0.30
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12921431 0.94
SCHEMBL373319 0.94
SCHEMBL12035111 0.94
SCHEMBL8177707 0.94
SCHEMBL373318 0.94
SCHEMBL15710308 0.88
Hydrochloric Acid SCHEMBL374156 0.88
Hydrochloric Acid SCHEMBL740121 0.88
Hydrochloric Acid SCHEMBL374157 0.88
Hydrochloric Acid SCHEMBL740122 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119278195-A Method and device for producing isocyanates 科思创德国股份有限公司 2025-01-07 CN claimed
EP-3945101-A1 CURABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM, AND METHODS OF FORMING THE SAME Covestro Deutschland AG (DE) 2022-02-02 EP claimed
EP-3921312-A1 CURABLE COMPOSITIONS, PRODUCTS AND ARTICLES FORMED THEREFROM, AND METHODS OF FORMING THE SAME Covestro LLC (US) 2021-12-15 EP claimed
CN-113365986-A Curable compositions, products and articles formed therefrom, and methods of forming the same 科思创有限公司 2021-09-07 CN claimed
US-10793667-B2 Curable compositions, products and articles formed therefrom, and methods of forming the same COVESTRO DEUTSCHLAND AG (DE) 2020-10-06 US claimed
US-20200255585-A1 CURABLE COMPOSITIONS, PRODUCTS AND ARTICLES FORMED THEREFROM, AND METHODS OF FORMING THE SAME COVESTRO LLC 2020-08-13 US claimed
WO-2020163464-A1 CURABLE COMPOSITIONS, PRODUCTS AND ARTICLES FORMED THEREFROM, AND METHODS OF FORMING THE SAME COVESTRO LLC (US) 2020-08-13 WO claimed
WO-2019183304-A1 URETDIONE BASED POLYURETHANE COMPOSITIONS COVESTRO LLC (US) 2019-09-26 WO claimed
US-20190292305-A1 URETDIONE BASED POLYURETHANE COMPOSITIONS COVESTRO LLC 2019-09-26 US claimed
EP-4700089-A1 POLYAMIDE RESIN COMPOSITION UBE Corporation (JP) 2026-02-25 EP disclosed
EP-4573154-A1 USE OF ADDITIVES FOR IMPROVING THE PROCESSING OF POLYETHYLENES BASF SE (DE) 2025-06-25 EP disclosed
EP-3742033-B1 MULTILAYER TUBE UBE CORP (JP) 2025-06-11 EP disclosed
CN-119731255-A Use of additives for improving the processing of polyethylene 巴斯夫欧洲公司 2025-03-28 CN disclosed
WO-2025021592-A1 RECYCLING OF POLYOLEFIN WASTE BY ADDING A AMIDE CLARIFIER BASF SE (DE) 2025-01-30 WO disclosed
US-6297320-B1 Curable compositions comprising acetoacetoxy and imine functionality THE SHERWIN-WILLIAMS COMPANY 2001-10-02 US disclosed
EP-1135444-A1 CURABLE COMPOSITIONS COMPRISING ACETOACETOXY AND IMINE FUNCTIONALITY THE SHERWIN-WILLIAMS COMPANY (US) 2001-09-26 EP disclosed
WO-2000031196-A1 CURABLE COMPOSITIONS COMPRISING ACETOACETOXY AND IMINE FUNCTIONALITY THE SHERWIN-WILLIAMS COMPANY (US) 2000-06-02 WO disclosed
US-5973076-A MOLDING; CONTROLLING TEMPERATURE IN PRESENCE OF AN AMIDE COMPOUND NEW JAPAN CHEMICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0776933-B1 Polybutene-1 resin composition and a method of accelerating the crystal transformation NEW JAPAN CHEM CO LTD (JP) 1999-08-04 EP disclosed
EP-0776933-A1 Polybutene-1 resin composition and a method of accelerating the crystal transformation NEW JAPAN CHEMICAL CO.,LTD. (JP) 1997-06-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292305-A1 URETDIONE BASED POLYURETHANE COMPOSITIONS PUF60, UTS2R, UTP20 THRB 4018/4885MEN1 3517/4885KMT2A 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.